ATE141284T1 - Verfahren zur herstellung von hochreinem fibrinogen - Google Patents
Verfahren zur herstellung von hochreinem fibrinogenInfo
- Publication number
- ATE141284T1 ATE141284T1 AT93400247T AT93400247T ATE141284T1 AT E141284 T1 ATE141284 T1 AT E141284T1 AT 93400247 T AT93400247 T AT 93400247T AT 93400247 T AT93400247 T AT 93400247T AT E141284 T1 ATE141284 T1 AT E141284T1
- Authority
- AT
- Austria
- Prior art keywords
- fibrinogen
- solution
- ionic strength
- high purity
- agarose
- Prior art date
Links
- 102000008946 Fibrinogen Human genes 0.000 title abstract 5
- 108010049003 Fibrinogen Proteins 0.000 title abstract 5
- 229940012952 fibrinogen Drugs 0.000 title abstract 5
- 238000004519 manufacturing process Methods 0.000 title abstract 2
- FBPFZTCFMRRESA-ZXXMMSQZSA-N D-iditol Chemical compound OC[C@@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-ZXXMMSQZSA-N 0.000 title 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 abstract 4
- 239000000243 solution Substances 0.000 abstract 4
- 229920000936 Agarose Polymers 0.000 abstract 3
- 238000005349 anion exchange Methods 0.000 abstract 2
- 239000011324 bead Substances 0.000 abstract 2
- 239000011780 sodium chloride Substances 0.000 abstract 2
- 125000003161 (C1-C6) alkylene group Chemical group 0.000 abstract 1
- 239000007983 Tris buffer Substances 0.000 abstract 1
- 125000003277 amino group Chemical group 0.000 abstract 1
- 239000007864 aqueous solution Substances 0.000 abstract 1
- 239000007853 buffer solution Substances 0.000 abstract 1
- 238000010828 elution Methods 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 210000002381 plasma Anatomy 0.000 abstract 1
- 125000006850 spacer group Chemical group 0.000 abstract 1
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/745—Blood coagulation or fibrinolysis factors
- C07K14/75—Fibrinogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/745—Blood coagulation or fibrinolysis factors
- C07K14/755—Factors VIII, e.g. factor VIII C (AHF), factor VIII Ag (VWF)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Zoology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Toxicology (AREA)
- Gastroenterology & Hepatology (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Hematology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Materials For Medical Uses (AREA)
- Compounds Of Unknown Constitution (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR9201238A FR2686883B1 (fr) | 1992-02-04 | 1992-02-04 | Procede de fabrication de fibrinogene de tres haute purete, fibrinogene de tres haute purete obtenu ainsi qu'une composition pharmaceutique le contenant. |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE141284T1 true ATE141284T1 (de) | 1996-08-15 |
Family
ID=9426316
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT93400247T ATE141284T1 (de) | 1992-02-04 | 1993-02-02 | Verfahren zur herstellung von hochreinem fibrinogen |
Country Status (7)
| Country | Link |
|---|---|
| EP (1) | EP0555135B1 (de) |
| AT (1) | ATE141284T1 (de) |
| DE (2) | DE69303941T2 (de) |
| DK (1) | DK0555135T3 (de) |
| ES (1) | ES2049701T3 (de) |
| FR (1) | FR2686883B1 (de) |
| GR (2) | GR930300095T1 (de) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0602173B1 (de) * | 1991-09-05 | 1999-05-26 | Baxter International Inc. | Topischer fibrinogenkomplex |
| ATE184884T1 (de) * | 1994-07-14 | 1999-10-15 | Croix Rouge De Belgique | Fibrinogenkonzentrate aus blutplasma, verfahren und anlage für ihre herstellung |
| DE10261126A1 (de) * | 2002-08-13 | 2004-03-04 | Aventis Behring Gmbh | Lagerungsstabile, flüssige Fibrinogen-Formulierung |
| DE102004009400A1 (de) | 2004-02-24 | 2005-09-08 | Zlb Behring Gmbh | Fibrinogen Reinigung |
| FR2887883B1 (fr) | 2005-06-29 | 2007-08-31 | Lab Francais Du Fractionnement | Procede de separation des proteines fibrinogene, facteur xiii et colle biologique d'une fraction plasmatique solubilisee et de preparation de concentres lyophilises desdites proteines |
| CA2728358C (en) | 2008-06-23 | 2016-06-14 | Bio-Products & Bio-Engineering Ag | Storage-stable, functionally intact fibrinogen |
| EP2619225B1 (de) * | 2010-09-20 | 2016-06-15 | Octapharma AG | Verfahren zur herstellung von fibrinogen |
| US10112972B2 (en) | 2012-03-13 | 2018-10-30 | Octapharma Ag | Process for production of fibrinogen and fibrinogen produced thereby |
| US10188965B2 (en) | 2012-12-05 | 2019-01-29 | Csl Behring Gmbh | Hydrophobic charge induction chromatographic depletion of a protein from a solution |
| US20140154233A1 (en) | 2012-12-05 | 2014-06-05 | Csl Limited | Method of purifying therapeutic proteins |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2632309B1 (fr) * | 1988-06-07 | 1990-08-24 | Lille Transfusion Sanguine | Procede de purification par voie chromatographique de proteines, notamment de facteur viii, et les produits obtenus |
| FR2644064B1 (fr) * | 1989-02-17 | 1994-05-27 | Aquitaine Dev Transf Sanguine | Procede de fabrication du facteur antihemophilique fviiic ayant une tres haute purete et facteur antihemophilique fviiic ainsi obtenu, ainsi que composition pharmaceutique le contenant |
| IT1248723B (it) * | 1990-06-12 | 1995-01-26 | Scalvo S P A | Processo per la purificazione del fattore viii e fattore viii ottenuto con tale processo |
-
1992
- 1992-02-04 FR FR9201238A patent/FR2686883B1/fr not_active Expired - Fee Related
-
1993
- 1993-02-02 ES ES93400247T patent/ES2049701T3/es not_active Expired - Lifetime
- 1993-02-02 DE DE69303941T patent/DE69303941T2/de not_active Expired - Fee Related
- 1993-02-02 DK DK93400247.8T patent/DK0555135T3/da active
- 1993-02-02 EP EP93400247A patent/EP0555135B1/de not_active Expired - Lifetime
- 1993-02-02 DE DE93400247T patent/DE555135T1/de active Pending
- 1993-02-02 AT AT93400247T patent/ATE141284T1/de not_active IP Right Cessation
- 1993-09-30 GR GR930300095T patent/GR930300095T1/el unknown
-
1996
- 1996-10-23 GR GR960402791T patent/GR3021419T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| FR2686883B1 (fr) | 1994-05-13 |
| DE555135T1 (de) | 1994-03-31 |
| DE69303941T2 (de) | 1997-03-27 |
| DE69303941D1 (de) | 1996-09-19 |
| ES2049701T3 (es) | 1997-01-16 |
| GR3021419T3 (en) | 1997-01-31 |
| GR930300095T1 (en) | 1993-09-30 |
| DK0555135T3 (da) | 1996-11-25 |
| EP0555135B1 (de) | 1996-08-14 |
| ES2049701T1 (es) | 1994-05-01 |
| EP0555135A1 (de) | 1993-08-11 |
| FR2686883A1 (fr) | 1993-08-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US4673734A (en) | Porous mineral support coated with an aminated polysaccharide polymer | |
| ATE179425T1 (de) | Verfahren zur abreicherung oder entfernung von endotoxinen | |
| ATE488582T1 (de) | Verfahren zur reinigung von faktor ix | |
| CA2058676C (en) | Process for isolating human albumin from supernatant iv, in particular iv-4, or from cohn's fraction v or from an analogous supernatant or fraction | |
| EP0121976A3 (de) | Teilweise gereinigter osteogener Faktor und Verfahren zu dessen Herstellung aus entmineralisierten Knochen oder Osteosarkom | |
| US5234991A (en) | Porous mineral support coated with an aminated polysaccharide polymer | |
| ATE196828T1 (de) | Verfahren zur expansion des tabaks | |
| DE359593T1 (de) | Chromatographische trennung von plasmaproteinen. | |
| ATE214074T1 (de) | Verfahren zur gewinnung von wachstumfaktoren aus milch oder milchderivaten | |
| ATE141284T1 (de) | Verfahren zur herstellung von hochreinem fibrinogen | |
| SE9603068D0 (sv) | Process for purifying a protein | |
| DE3751389D1 (de) | Verfahren zur Trennung von Proteinen. | |
| DK0383234T3 (da) | Pasteuriseret, renset von Willebrand-faktor-koncentrat og fremgangsmåde til dets fremstilling | |
| DE3587298D1 (de) | Verfahren zur reinigung des hepatitis-oberflaechen-antigens und das so erhaltene produkt. | |
| DE69902639D1 (de) | Verbessertes verfahren zur herstellung von faktor viii | |
| US4985144A (en) | Affinity chromatography material for antigens of the bacteria of the Bordetella genus | |
| KR960023066A (ko) | 전에스 (s) 2 펩티드 함유 비 (b) 형 간염 표면항원의 정제 방법 | |
| WO1996016084A3 (en) | A method of identifying cftr-binding compounds useful for activating chloride conductance in animal cells | |
| RU2148411C1 (ru) | Способ получения с помощью хроматографических методов вирусно-инактивированной фракции, содержащей фактор viii | |
| ATE97449T1 (de) | Methode zur reinigung und isolierung von zwei ionischen formen von somatomedin. | |
| EP0910581B1 (de) | Verfahren zur affinitätschromatographischen aufreinigung von faktor viii | |
| DE19521313A1 (de) | Verfahren zur affinitätschromatographischen Aufreinigung von Faktor VIII | |
| DE69415664D1 (de) | Methode zur trennung von glykosylierten und unglykosylierten proteinen | |
| JPH03244390A (ja) | 大腸菌由来物質の除去方法 | |
| JPS61191699A (ja) | マウスインタ−フエロンの精製法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| REN | Ceased due to non-payment of the annual fee |